about
Fibrinolytic agents for peripheral arterial occlusionSystematic reviews and meta-analyses for more profitable strategies in peripheral artery diseaseAntithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Axillary artery thrombosis in a neonate in utero: a case reportPurification and characterization of mutant miniPlasmin for thrombolytic therapy.
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Fibrinolytic agents for peripheral arterial occlusion
@ast
Fibrinolytic agents for peripheral arterial occlusion
@en
Fibrinolytic agents for peripheral arterial occlusion
@en-gb
Fibrinolytic agents for peripheral arterial occlusion
@nl
type
label
Fibrinolytic agents for peripheral arterial occlusion
@ast
Fibrinolytic agents for peripheral arterial occlusion
@en
Fibrinolytic agents for peripheral arterial occlusion
@en-gb
Fibrinolytic agents for peripheral arterial occlusion
@nl
prefLabel
Fibrinolytic agents for peripheral arterial occlusion
@ast
Fibrinolytic agents for peripheral arterial occlusion
@en
Fibrinolytic agents for peripheral arterial occlusion
@en-gb
Fibrinolytic agents for peripheral arterial occlusion
@nl
P2093
P2860
P1476
Fibrinolytic agents for peripheral arterial occlusion
@en
P2093
David C Berridge
David O Kessel
Iain Robertson
P2860
P356
10.1002/14651858.CD001099.PUB2
P577
2010-03-17T00:00:00Z